Market revenue in 2022 | USD 233.0 million |
Market revenue in 2030 | USD 450.4 million |
Growth rate | 8.6% (CAGR from 2022 to 2030) |
Largest segment | Auto-contouring software |
Fastest growing segment | PET/CT Deformable Software |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, DICOM RT Software |
Key market players worldwide | Elekta AB ADR, GE HealthCare Technologies Inc Common Stock, RaySearch Laboratories AB Class B, Prowess |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to brachytherapy treatment planning systems market will help companies and investors design strategic landscapes.
Auto-contouring software was the largest segment with a revenue share of 31.42% in 2022. Horizon Databook has segmented the U.S. brachytherapy treatment planning systems market based on auto-contouring software, multi-modality software, pet/ct deformable software, dicom rt software covering the revenue growth of each sub-segment from 2017 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. brachytherapy treatment planning systems market, including forecasts for subscribers. This country databook contains high-level insights into U.S. brachytherapy treatment planning systems market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account